| Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis M Arbyn, E Weiderpass, L Bruni, S de Sanjosé, M Saraiya, J Ferlay, ... The Lancet Global Health 8 (2), e191-e203, 2020 | 3183 | 2020 |
| Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials G Ronco, J Dillner, KM Elfström, S Tunesi, PJF Snijders, M Arbyn, ... The lancet 383 (9916), 524-532, 2014 | 1895 | 2014 |
| Metaprop: a Stata command to perform meta-analysis of binomial data VN Nyaga, M Arbyn, M Aerts Archives of public health 72, 1-10, 2014 | 1884 | 2014 |
| Worldwide burden of cervical cancer in 2008 M Arbyn, X Castellsagué, S de Sanjosé, L Bruni, M Saraiya, F Bray, ... Annals of oncology 22 (12), 2675-2686, 2011 | 1552 | 2011 |
| Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis M Kyrgiou, G Koliopoulos, P Martin-Hirsch, M Arbyn, W Prendiville, ... The Lancet 367 (9509), 489-498, 2006 | 1523 | 2006 |
| Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer M Arbyn, G Ronco, A Anttila, CJLM Meijer, M Poljak, G Ogilvie, ... Vaccine 30, F88-F99, 2012 | 978 | 2012 |
| Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis M Arbyn, M Kyrgiou, C Simoens, AO Raifu, G Koliopoulos, P Martin-Hirsch, ... Bmj 337, 2008 | 913 | 2008 |
| Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries J Cuzick, M Arbyn, R Sankaranarayanan, V Tsu, G Ronco, MH Mayrand, ... Vaccine 26, K29-K41, 2008 | 912 | 2008 |
| Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older CJLM Meijer, J Berkhof, PE Castle, AT Hesselink, EL Franco, G Ronco, ... International journal of cancer 124 (3), 516-520, 2009 | 853 | 2009 |
| HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis C Ndiaye, M Mena, L Alemany, M Arbyn, X Castellsagué, L Laporte, ... The Lancet Oncology 15 (12), 1319-1331, 2014 | 851 | 2014 |
| The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries MC Grant, L Geoghegan, M Arbyn, Z Mohammed, L McGuinness, ... PloS one 15 (6), e0234765, 2020 | 842 | 2020 |
| European guidelines for quality assurance in cervical cancer screening. —summary document M Arbyn, A Anttila, J Jordan, G Ronco, U Schenck, N Segnan, H Wiener, ... Annals of Oncology 21 (3), 448-458, 2010 | 803 | 2010 |
| Comprehensive control of human papillomavirus infections and related diseases FX Bosch, TR Broker, D Forman, AB Moscicki, ML Gillison, J Doorbar, ... Vaccine 31, H1-H31, 2013 | 795 | 2013 |
| Clinical applications of HPV testing: a summary of meta-analyses M Arbyn, P Sasieni, CJLM Meijer, C Clavel, G Koliopoulos, J Dillner Vaccine 24, S78-S89, 2006 | 772 | 2006 |
| Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis M Arbyn, F Verdoodt, PJF Snijders, VMJ Verhoef, E Suonio, L Dillner, ... The lancet oncology 15 (2), 172-183, 2014 | 724 | 2014 |
| Liquid compared with conventional cervical cytology: a systematic review and meta-analysis M Arbyn, C Bergeron, P Klinkhamer, P Martin-Hirsch, AG Siebers, ... Obstetrics & Gynecology 111 (1), 167-177, 2008 | 705 | 2008 |
| Cytology versus HPV testing for cervical cancer screening in the general population G Koliopoulos, VN Nyaga, N Santesso, A Bryant, PPL Martin‐Hirsch, ... Cochrane database of systematic reviews, 2017 | 546 | 2017 |
| Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia M Arbyn, F Buntinx, MV Ranst, E Paraskevaidis, P Martin-Hirsch, J Dillner Journal of the National Cancer Institute 96 (4), 280-293, 2004 | 544 | 2004 |
| Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses M Arbyn, SB Smith, S Temin, F Sultana, P Castle Bmj 363, 2018 | 535 | 2018 |
| Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening F Bray, AH Loos, P McCarron, E Weiderpass, M Arbyn, H Møller, ... Cancer Epidemiology Biomarkers & Prevention 14 (3), 677-686, 2005 | 504 | 2005 |
